EP300 and liver cancer: The super-enhancer “writer” p300, super-enhancer “reader” BRD4, and super-enhancer activity regulators CDK7 and MED1 are often over-expressed in human liver cancer tissues, and their over-expression predicts poor patient prognosis [17].